Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels


Amicus Therapeutics Sees FY 2021 Galadold Revs $300M-$315M; Sees Non-GAAP Operating Expenses $410M-$420M


Benzinga | Mar 1, 2021 07:06AM EST

Amicus Therapeutics Sees FY 2021 Galadold Revs $300M-$315M; Sees Non-GAAP Operating Expenses $410M-$420M






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC